F13.91
Sedative, hypnotic or anxiolytic use, unspecified, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.91 refers to a condition where an individual has previously used sedatives, hypnotics, or anxiolytics but is currently in a state of remission. This code is used by healthcare providers to document a history of such substance use that is not presently active. Understanding this condition involves recognizing the nature of these medications, their uses, and what remission signifies in this context.
Causes & Symptoms
Clinical Causes: Initial use of sedatives, hypnotics, or anxiolytics to manage anxiety, insomnia, or other conditions Prescription of medications like benzodiazepines, barbiturates, or other drugs within this class Abuse or dependence leading to medical treatment and eventual remission Underlying mental health issues that prompted initial use, such as anxiety disorders or sleep disturbances Successful treatment programs or natural resolution leading to sustained remission
Key Symptoms: History of medication use to manage anxiety or sleep problems Absence of current symptoms related to sedative, hypnotic, or anxiolytic dependence Potential past experiences of withdrawal symptoms during previous discontinuation No ongoing interference with daily functioning due to substance use
Diagnostic & Treatment
Diagnosis Path: Diagnosis of F13.91 is primarily based on clinical history and medical records. Healthcare professionals assess previous use of sedatives, hypnotics, or anxiolytics, and determine that the patient is currently in remission. This involves confirming the absence of active substance use and related symptoms. Sometimes, laboratory tests or urine screenings may support the history, but the diagnosis mainly rests on clinical judgment and documentation.
Treatment Protocols: Since F13.91 indicates a state of remission, active treatment may not be necessary unless there are underlying conditions. Monitoring and support might include: - Continued mental health care or counseling to maintain remission - Education about avoiding relapse - Addressing any residual or associated mental health issues - Lifestyle modifications to promote overall well-being In cases where relapse occurs or the patient develops new symptoms, treatment strategies might be revisited under medical supervision. Long-term management often emphasizes relapse prevention and addressing the root causes of initial substance use.
Clinical Advice & FAQs
Billing Guidance
Is F13.91 a billable ICD-10 code?
Yes, F13.91 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.91?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference